These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 17006365)

  • 21. Changes of D-dimer after total hip arthroplasty in patients with and without intraoperative heparin.
    Maezawa K; Nozawa M; Aritomi K; Kubota M; Shitoto K; Kurosawa H
    Arch Orthop Trauma Surg; 2008 Jan; 128(1):37-40. PubMed ID: 17522875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylaxis of deep venous thrombosis after total hip arthroplasty by using intermittent compression of the plantar venous plexus.
    Stannard JP; Harris RM; Bucknell AL; Cossi A; Ward J; Arrington ED
    Am J Orthop (Belle Mead NJ); 1996 Feb; 25(2):127-34. PubMed ID: 8640382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery.
    Levine MN; Gent M; Hirsh J; Weitz J; Turpie AG; Powers P; Neemeh J; Willan A; Skingley P
    Arch Intern Med; 1996 Apr; 156(8):851-6. PubMed ID: 8774203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of combined modality prophylaxis including short-duration warfarin to prevent venous thromboembolism after total hip arthroplasty.
    Keeney JA; Clohisy JC; Curry MC; Maloney WJ
    J Arthroplasty; 2006 Jun; 21(4):469-75. PubMed ID: 16781396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mobile compression device compared with low-molecular-weight heparin for prevention of venous thromboembolism in total hip arthroplasty.
    Hardwick ME; Pulido PA; Colwell CW
    Orthop Nurs; 2011; 30(5):312-6. PubMed ID: 21934585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for pulmonary embolism and the effects of fondaparinux after total hip and knee arthroplasty: a retrospective observational study with use of a national database in Japan.
    Nagase Y; Yasunaga H; Horiguchi H; Hashimoto H; Shoda N; Kadono Y; Matsuda S; Nakamura K; Tanaka S
    J Bone Joint Surg Am; 2011 Dec; 93(24):e146. PubMed ID: 22258781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DVT prophylaxis: better living through chemistry: affirms.
    Pellegrini VD
    Orthopedics; 2010 Sep; 33(9):642. PubMed ID: 20839678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VenaFlow plus Lovenox vs VenaFlow plus aspirin for thromboembolic disease prophylaxis in total knee arthroplasty.
    Westrich GH; Bottner F; Windsor RE; Laskin RS; Haas SB; Sculco TP
    J Arthroplasty; 2006 Sep; 21(6 Suppl 2):139-43. PubMed ID: 16950076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraoperative heparin thromboembolic prophylaxis in primary total hip arthroplasty. A prospective, randomized, controlled, clinical trial.
    Huo MH; Salvati EA; Sharrock NE; Brien WW; Sculco TP; Pellicci PM; Mineo R; Go G
    Clin Orthop Relat Res; 1992 Jan; (274):35-46. PubMed ID: 1729021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of pneumatic compression stocking prophylaxis in the prevention of deep venous thrombosis and pulmonary embolism following 139 lumbar laminectomies with instrumented fusions.
    Epstein NE
    J Spinal Disord Tech; 2006 Feb; 19(1):28-31. PubMed ID: 16462215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of lower-dose unfractionated heparin for prophylaxis of deep vein thrombosis and pulmonary embolism in an Asian population.
    Ugaki H; Enomoto T; Fujiwara K; Kimura T; Kawasaki T
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):585-9. PubMed ID: 18685443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of venous thromboembolic disease after total hip and knee arthroplasty.
    Lieberman JR; Pensak MJ
    J Bone Joint Surg Am; 2013 Oct; 95(19):1801-11. PubMed ID: 24088973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid-inflation intermittent pneumatic compression for prevention of deep venous thrombosis.
    Eisele R; Kinzl L; Koelsch T
    J Bone Joint Surg Am; 2007 May; 89(5):1050-6. PubMed ID: 17473143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of calf-thigh intermittent pneumatic compression device after total hip arthroplasty: comparative analysis with plantar compression on the effectiveness of reducing thrombogenesis and leg swelling.
    Fujisawa M; Naito M; Asayama I; Kambe T; Koga K
    J Orthop Sci; 2003; 8(6):807-11. PubMed ID: 14648269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
    Asopa V; Cobain W; Martin D; Keene G; Bauze A
    ANZ J Surg; 2015 Sep; 85(9):652-7. PubMed ID: 25997601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical efficacy of mechanical thromboprophylaxis without anticoagulant drugs for elective hip surgery in an Asian population.
    Sugano N; Miki H; Nakamura N; Aihara M; Yamamoto K; Ohzono K
    J Arthroplasty; 2009 Dec; 24(8):1254-7. PubMed ID: 19577898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the first-generation AAOS clinical guidelines on the prophylaxis of venous thromboembolic events in patients undergoing total joint arthroplasty: experience with 3289 patients from a single institution.
    Lewis CG; Inneh IA; Schutzer SF; Grady-Benson J
    J Bone Joint Surg Am; 2014 Aug; 96(16):1327-32. PubMed ID: 25143492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.